Journal of Clinical Oncology 临床肿瘤· Hanny Al-Samkari·· 2026-10-02AI 评分57
阿伐曲泊帕对比安慰剂治疗胃肠道癌症持续性化疗诱导性血小板减少症的II期ACT-GI试验
Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial
AI 导读
阿伐曲泊帕对比安慰剂用于胃肠道癌症持续性化疗诱导性血小板减少症的II期ACT-GI试验在《临床肿瘤学杂志》发表,初步评估了药物在此适应症下的安全性与疗效。
来源:Journal of Clinical Oncology 临床肿瘤 · ascopubs.org